Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September 2024 as against net loss of Rs 3.57 crore during the previous quarter ended September 2023. Sales declined 13.63% to Rs 12.86 crore in the quarter ended September 2024 as against Rs 14.89 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.8614.89 -14 OPM %-21.15-6.04 - PBDT-4.05-1.86 -118 PBT-5.76-3.57 -61 NP-5.76-3.57 -61 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live News

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024 as against net loss of Rs 5.33 crore during the previous quarter ended June 2023. Sales rose 21.83% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 10.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8910.58 22 OPM %-16.99-24.76 - PBDT-3.48-3.68 5 PBT-5.17-5.33 3 NP-5.17-5.33 3 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live News